Calcium channel blockers - the effect on renal changes in clinical and experimental diabetes: an overview.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/15.5.581PMID 10809795
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive Type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial

  2004cited by this paper
• Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.

  2000cited by this paper
• Effect of the calcium channel blocker nitrendipine in normotensive and spontaneously hypertensive, diabetic rats on kidney morphology and urinary albumin excretion.

  1999cited by this paper
• The Calcium Channel Blocker Nitrendipine Attenuates Renal and Glomerular Hypertrophy in Diabetic Rats

  1999cited by this paper
• Calcium antagonists and cardiovascular risk in diabetes. A review of the evidence.

  1999cited by this paper
• Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

  1998cited by this paper
• Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM

  1998cited by this paper
• The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension.

  1998cited by this paper
• Calcium antagonists and cardiovascular risk in diabetes.

  1998cited by this paper
• Calcium antagonists and renal disease.

  1998cited by this paper
• Calcium-channel blockers for hypertension--uncertainty continues.

  1998cited by this paper
• Effects of Lisinopril and Nifedipine on the Progression to Overt Albuminuria in IDDM Patients With Incipient Nephropathy and Normal Blood Pressure

  1998cited by this paper
• Contrasting effects of calcium channel blockade versus converting enzyme inhibition on proteinuria in African Americans with non-insulin-dependent diabetes mellitus and nephropathy.

  1997cited by this paper
• Differences Between Nisoldipine and Lisinopril on Glomerular Filtration Rates and Albuminuria in Hypertensive IDDM Patients With Diabetic Nephropathy During the First Year of Treatment

  1997cited by this paper
• Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.

  1997cited by this paper
• Renal effects of antihypertensive therapy in uninephrectomized diabetic rats

  1997cited by this paper
• Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat.

  1996cited by this paper
• Nitrendipine and enalapril improve albuminuria and glomerular filtration rate in non-insulin dependent diabetes.

  1996cited by this paper
• Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.

  1996cited by this paper
• Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

  1996cited by this paper
• Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.

  1996cited by this paper
• Effects of Dihydropyridine Calcium Antagonists on Albuminuria in Patients with Diabetes

  1996cited by this paper
• Effects of Cilazapril and Amlodipine on Kidney Function in Hypertensive NIDDM Patients

  1996cited by this paper
• Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

  1996cited by this paper
• Comparative effects of ramipril and nitrendipine on albuminuria in hypertensive patients with non-insulin-dependent diabetes mellitus and impaired renal function.

  1995cited by this paper
• Comparison of effects of ACE inhibition with calcium channel blockade on renal disease in a model combining genetic hypertension and diabetes.

  1995cited by this paper
• Effect of 1-year treatment with nitrendipine versus enalapril on urinary albumin and alpha 1-microglobulin excretion in microalbuminuric patients with type 1 diabetes mellitus. A randomized, single-blind comparative study.

  1994cited by this paper
• Long-term treatment with either enalapril or nitrendipine stabilizes albuminuria and increases glomerular filtration rate in non-insulin-dependent diabetic patients.

  1994cited by this paper
• Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria

  1994cited by this paper
• Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.

  1994cited by this paper
• Effects of different antihypertensive treatments on morphologic progression of diabetic nephropathy in uninephrectomized dogs.

  1994cited by this paper
• Short‐term effects of quinapril and nifedipine on early renal changes in streptozotocin‐induced diabetes in rats

  1994cited by this paper
• Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats.

  1993cited by this paper
• Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Comparative effects of different antihypertensive treatments on progression of diabetic renal disease.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy.

  1993cited by this paper
• Calcium antagonists and converting enzyme inhibitors reduce renal injury by different mechanisms.

  1993cited by this paper
• Effects of nisoldipine on hypertension and glomerulosclerosis in Cohen diabetic rat with Goldblatt hypertension.

  1993cited by this paper
• A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.

  1993cited by this paper
• Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis.

  1992cited by this paper
• Nifedipine versus fosinopril in uninephrectomized diabetic rats.

  1992cited by this paper
• Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection.

  1992cited by this paper
• Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy

  1991cited by this paper
• Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus.

  1990cited by this paper
• Hemodynamic, Renal, and Humoral Effects of the Calcium Entry Blocker Nicardipine and Converting Enzyme Inhibitor Captopril in Hypertensive Type II Diabetic Patients with Nephropathy

  1989cited by this paper
• Diabetic nephropathy in the rat: differing renal effects of an angiotensin converting enzyme inhibitor and a calcium inhibitor.

  1988cited by this paper
• Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.

  1988cited by this paper
• Disparate effects of angiotensin converting enzyme inhibitor and calcium blocker treatment on the preservation of renal structure and function following subtotal nephrectomy or streptozotocin-induced diabetes in the rat.

  1987cited by this paper
• Effect of calcium antagonists on hypertension and diabetes in new hypertensive diabetic models.

  1987cited by this paper

• Effects of Nifedipine on Cation Transport and Na - K-ATPase Activity in Erythrocytes and Electrolyte Homeostasis in Rats

  2012cites this paper
• Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.

  2010cites this paper
• CALCIUM CHANNEL BLOCKERS IN THE PREVENTION OF END STAGE RENAL DISEASE: A REVIEW

  2004cites this paper
• Amelioration of diabetic nephropathy by dried Rehmanniae Radix (Di Huang) extract.

  2004cites this paper
• Effect of Combination Therapy with a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor on Renal Hypertrophy and Urinary Albumin Excretion in Diabetic Rats

  2003cites this paper
• Extracellular signals and intracellular pathways in diabetic nephropathy

  2001cites this paper
• Extracellular signals and intracellular pathways in diabetic nephropathy

  2001influential citation
• Are calcium antagonists effective in preventing complications of hypertension and progression of renal disease?

  2000cites this paper
• Calcium channel blockers: do they have pleiotropic effects on atherosclerosis?

  2000cites this paper